According to industry statistics, as of December 19, a total of 87 pharmaceutical companies in the A-shares announced their 2018 performance forecasts. Among them, nearly 75% of the pharmaceutical companies reported good results, a total of 65, and Xinhecheng, Xinlitai, The eight pharmaceutical companies of Kelun Pharmaceutical, Ruikang Pharmaceutical, Livzon Group, Hualan Biological, Yan'an Bikang and Yifan Pharmaceutical are expected to have a net profit of over RMB 1 billion. There are 5 companies that are expected to lose money, and Hengkang Medical and Shanghai Lai Shi lose more than 1 billion yuan. Below, the author will give a brief introduction to eight pharmaceutical companies with a net profit of over $1 billion. Xinhecheng Xinhecheng has been in existence for nearly 20 years since its inception and was listed on the Shenzhen SME Board in 2004. The company specializes in fine chemicals such as nutritional products, flavors and fragrances, APIs, and new polymer materials. It has been ranked among the top 100 Chinese pharmaceutical companies and the top 100 listed companies in China for many years. The company expects that the 2018 performance change will be 2.889 billion to 3.409 billion yuan, which will increase by 1.704 billion yuan over the same period last year. This is also the only existence of 8 pharmaceutical companies in the performance forecast to break 2 billion yuan. Xinlitai Xinlitai is a comprehensive pharmaceutical group integrating research, development, production and sales of pharmaceutical products. It was listed on the Shenzhen Stock Exchange in 2009. Focus on cardiovascular and cerebrovascular, diabetes and complications, anti-tumor and orthopedics, focusing on three main lines of high-end chemical drugs, innovative bio-pharmaceuticals and medical devices. The company's business is distributed in 38 countries and regions around the world such as China, the United States, Germany, France and Japan. The company expects that the 2018 performance change will be 1.452 billion to 1.597 billion yuan, which will increase slightly by 1.452 billion yuan over the same period last year. Columbine Pharmaceuticals Kelun Pharmaceutical was listed on the Shenzhen Stock Exchange in June 2010. Up to now, Cologne has applied for more than 3,000 patents and obtained more than 2,000 patents. It has launched more than 300 major drugs in the fields of cancer, bacterial infection and parenteral nutrition. The company expects that the 2018 performance change will be 1.16 billion to 1.385 billion yuan, which will increase by 749 million yuan over the same period last year. Ruikang Pharmaceutical Ruikang Pharmaceutical focuses on the pharmaceutical distribution industry and was launched in 2011. According to the company's announcement, Ruikang Pharmaceutical achieved a net cash flow of operating activities of nearly 1.5 billion yuan in a single quarter in the third quarter of 2018. The company expects that the 2018 performance change will be 1.109 billion to 1.27 billion yuan, which will increase slightly by 10.08 billion yuan over the same period last year. Livzon Group Livzon Pharmaceutical Group Co., Ltd. is a comprehensive enterprise group integrating pharmaceutical R&D, production and sales. Founded in January 1985, it is a top 50 Chinese pharmaceutical and national technology innovation demonstration enterprise. The company expects that the 2018 performance change will be 1.128 billion to 1.251 billion yuan, which will be reduced by 4.429 billion yuan over the same period last year. Hualan Bio Established in 1992, Hualan Biological is a national key high-tech enterprise engaged in the research and development and production of blood products. Its domestic market share of leading products ranks in the forefront of the industry, and comprehensive strength companies have entered the top 30 of China's national pharmaceutical industry. The company expects that the 2018 performance change will be 821 million to 1.108 billion yuan, which will increase by 821 million yuan over the same period last year. Yanan Bikang After more than 20 years of development, Yanan Bikang has become a modern large-scale pharmaceutical enterprise group integrating raw material medicine, Chinese patent medicine, chemical medicine, biological preparation, vaccine research and development, health products, health drink production and marketing. The company expects that the 2018 performance change will be 803 million to 1.071 billion yuan, which will be 893 million yuan more than the same period last year. Yifan Pharmaceutical In recent years, Yifan Pharmaceutical has continuously innovated and upgraded and upgraded to focus on key areas such as macromolecular biopharmaceuticals, high-end pharmaceuticals and specialty Chinese medicines.
Medical Cold Patch
Throat Pain Relief Patch,Throat Pain Relief Pad,Throat Pain Relief Plaster,Antitussive Patch Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.sdxjmedical.com
The company expects that the 2018 performance change will be 718 million to 1.109 billion yuan, which will be slightly less than the previous year's net profit by 1.305 billion yuan.
Throat Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 36 round pieces
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for acute and chronic tonsillitis.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions] Store below 30c in a dry place away from heat and direct sunlight.